FDA Drug Application (075616) for NIZATIDINE by WATSON LABS

Back to FDA Applications sponsored by WATSON LABS

Application Number075616
Product Number001
FormCAPSULE;ORAL
Dosage150MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameNIZATIDINE
Active IngredientNIZATIDINE

Active IngredientCount
List of drugs with Active Ingredient NIZATIDINE3


Back to FDA Applications sponsored by WATSON LABS